Bruker’s BRKR strong growth reflects its fundamental commitment to innovate high-value solutions and ongoing portfolio ...

Bruker Corporation (Nasdaq: BRKR) today announces the launch of the new X4 POSEIDON™, a high-performance 3D X-ray microscope ...

Bruker Corporation BRKR recently launched the new X4 POSEIDON, a high-performance 3D X-ray microscope (XRM) using micro-Computed Tomography (microCT). Representing a significant leap in benchtop XRM ...

Bruker Corporation (Nasdaq: BRKR) announced today that it will unveil significant advancements in spatial biology at the 2025 ...

Bruker targets approximately 140 basis points ... Laukien explained that while NIH exposure is under 5%, other growth drivers, such as microbiology, semiconductors, and emerging China stimulus ...

as well as in clinical microbiology and molecular diagnostics. For more information, please visit www.bruker.com.

Bruker Spatial Biology, a division of Bruker Corporation, provides advanced spatial solutions, including instruments, assays, software, and services to support life sciences research. The CosMx™ ...

Bruker Corp (NASDAQ:BRKR ... and strong performance in microbiology, semiconductor, AI, and applied markets. We have built in some NIH uncertainty into our guidance, but we are confident in ...

As part of the development of the SkyScan 1278, Bruker has created a new micro-CT spatial beam shaper, which reduces the absorbed dose by up to five times while maintaining high quality image output.

Bruker Corporation (Nasdaq: BRKR) announced today that its senior leadership will present at the following conferences: ...

Bruker Corporation (Nasdaq: BRKR) today announces the launch of the new X4 POSEIDON™, a high-performance 3D X-ray microscope (XRM) using micro-Computed Tomography (microCT). This innovative ...